title: [Pharmacoeconomic model of the use of rifabutin in new cases of pulmonary tuberculosis].
abstract: The formalized procedures to commensurate the results and expenditures were used to make a comprehensive evaluation of the clinical efficiency and economical expediency of purposeful application of rifabutin in new cases of disseminated and destructive pulmonary tuberculosis.
authors.forename: B L
authors.initials: BL
authors.lastname: Mednikov
authors.forename: D I
authors.initials: DI
authors.lastname: Plaksin
authors.forename: S A
authors.initials: SA
authors.lastname: Piiavskiĭ
mesh_terms: D000904:Antibiotics, Antitubercular / Q000008:administration & dosage / Q000191:economics* / Q000627:therapeutic use*; D006801:Humans; D008962:Models, Theoretical; D012008:Recurrence; D017828:Rifabutin / Q000008:administration & dosage / Q000191:economics* / Q000627:therapeutic use*; D013997:Time Factors; D014397:Tuberculosis, Pulmonary / Q000145:classification / Q000188:drug therapy* / Q000191:economics* / Q000401:mortality
chemical_list: D000904:Antibiotics, Antitubercular; D017828:Rifabutin